PubMed Health⌕ Search

PubMed · 6275248

Possible ranitidine hepatitis.

Abstract

A 63-year-old woman developed anicteric hepatitis after two weeks of therapy with ranitidine. Despite continuation of therapy, her symptoms resolved within five days and transaminase levels returned to normal in the next four weeks, at which time use of the drug ceased. The gamma-glutamyl transpeptidase level returned to normal two weeks later. Although liver biopsy and drug rechallenge were not performed, no other cause for the reaction could be found.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G D Barr, D W Piper. 1981-10-17. Possible ranitidine hepatitis.. https://doi.org/10.5694/j.1326-5377.1981.tb101036.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.

BACKGROUND: Methotrexate-induced liver damage in psoriasis has led to dermatologic guidelines that stipulate monitoring of liver injury by means of serial liver biopsies. Recent literature data suggest that methotrexate may be considerably less hepatotoxic than previously assumed. AIM: To evaluate prevalence and development of liver injury in methotrexate treated psoriasis. METHODS: Retrospective chart review (1976-2005). RESULTS: Hundred and twenty-five patients (F58/M67; mean age 45.0, SD 12.7 years) received a median cumulative methotrexate dose of 2,113 mg (range 180-20 235) over a median period of 228 weeks (range 16-1763). Two hundred and seventy eight liver biopsies were analysed and 71% were classified as Roenigk grade I, 14% as Roenigk II, 14% grade IIIa, 2% grade IIIB and 2% grade IV. Liver injury was not associated with cumulative dose, weekly prescribed dose, age or duration of treatment. Obesity and diabetes were significant risk factors for liver injury. A total of 68 patients had multiple biopsies, 3% improved, 72% did not change and in 25% liver histology deteriorated. The majority of cases (84%) that progressed to Roenigk 2 had a cumulative dose of 1,500-6,000 mg. CONCLUSIONS: Methotrexate-related liver injury is less frequent than previously thought and mostly occurred at cumulative dose of <6,000 mg. Diabetes and being overweight are significantly correlated with liver injury.

Chemical and Drug Induced Liver Injury↗